1. There is potential to improve drug counselling to ensure that patients act safely and appropriately.
2. Improved patient education could reduce risks around vaccination, cancer screening and infection-related drug cessation.
3. Rheumatology nurse education is highly valued by patients, particularly those with complex disease.
The objective of the study was to measure patient attitudes and experience of information received during drug counselling for rheumatoid arthritis (RA) medications. This is a cross-sectional UK postal questionnaire study. Three RA patient groups—disease-modifying antirheumatic drugs (DMARDs) only, first anti-tumour necrosis factor (anti-TNF) and failed anti-TNF—were sent postal questionnaires. Data on patient history/demographics, drug counselling experience, knowledge of drug side effects, attitudes to vaccinations, cancer screening and blood borne virus testing was collected; 264/679 (39%) patients responded (median age 65 years, 66% female, median disease duration 15 years). Drug information from rheumatology nurses, rheumatology doctors and information leaflets was most useful. Thirty-eight percent of respondents felt reassured by information received, but 37% felt more worried. Forty percent of participants were aware of important drug side effects. Although 42–65% of patients understood they should temporarily halt anti-TNF therapy with concurrent infection, 75% of patients recalled continuing therapy despite infection. Thirteen percent believed that all vaccinations (including travel vaccinations) were safe while taking anti-TNF. Uptake of UK cancer screening programmes was between 87 and 94%, except prostate screening (47%). Most participants were not aware that they may need to discontinue their anti-TNF if they developed cancer. The majority of participants felt neutral/reassured by the prospect of viral hepatitis (95%) and HIV (91%) testing. Although drug counselling is a well-established part of clinical care, there is potential for further improvement to ensure that patients’ knowledge empowers them to act safely. Particular areas for improvement included the following: patients halting DMARDs/anti-TNF therapy during infections, knowledge regarding vaccinations and prostate cancer screening uptake.
Lovisi Neto BE, Jennings F, Barros Ohashi C, Silva PG, Natour J (2009) Evaluation of the efficacy of an educational program for rheumatoid arthritis patients. Clin Exp Rheumatol 27:28–34 PubMed
Arkell P, Ryan S, Brownfield A, Cadwgan A, Packham J (2013) Patient experiences, attitudes and expectations towards receiving information about anti-TNF medication—“it could give me two heads and I’d still try it!”. BMC Musculoskelet Disord 10:165 CrossRef
Marshall NJ, Wilson G, Lapworth K, Kay LJ (2004) Patients’ perceptions of treatment with anti-TNF therapy for rheumatoid arthritis: a qualitative study. Rheumatology (Oxford) 43:1034–1038 CrossRef
British Society for Rheumatology. The British Society for Rheumatology Biologics Register [ www.rheumatology.org.uk/bsr_biologics_register/default.aspx. Accessed 2012]
Kavanaugh A, Cohen S, Cush J (2004) The evolving use of tumour necrosis factors in rheumatoid arthritis. J Rheumatol 31:1881–1884 PubMed
English indices of deprivation 2010: Department for Communities and Local Government. 24 March 2011 Ref: ISBN 978140982924
Achievable standards, Benchmarks for reporting, and Criteria for evaluating cervical cytopathology (3rd Edition) January 2013 | ISBN 978 1 84463 081 3
NHS Breast Screening Programme 2012 Annual Review ISBN 978–1–84463-093-6
NHS public health England: http://www.cancerscreening.nhs.uk/index.html
Ding T, Ledingham J, Luqmani R, Westlake S, Hyrich K, Lunt M, Standards, Audit and Guidelines Working Group of BSR Clinical Affairs Committee, BHPR et al (2010) BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies. Rheumatology (Oxford) 49:2217–2219 CrossRef
Carr A, Hewlett S, Hughes R, Mitchell H, Ryan S, Carr M et al (2003) Rheumatology outcomes: the patient’s perspective. J Rheumatol 30:880–883 PubMed
Health protection agency. Time to test for HIV: expanding HIV testing in healthcare and community services in England. HPA11–04 London 2011
- Patient experiences, attitudes and expectations towards receiving information about anti-TNF medication: a quantitative study
- Springer London
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
e.Med Kampagnen-Visual, Mail Icon II